12.500
+4,17%
2026-10-19
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +10.0% | -62.3% | 1 / 3 | -15.0% | +1.94 pp | +1.11 pp | +6.9% | 0.75 | 18.33 | 188 | −15,0% | 9,2 | +10,0% | 18.33 | 12.77 | +43,6% |
| Pts | 0 | 0 | 4 | 0 | 8 | 8 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 12.500 (close price on 2026-10-19)EPS (TTM): 681,8
Financial charts
1.Revenue & growth
VND bn188Q2/26
1.Revenue & growth
VND bn188Q2/26
2.Profit & growth
VND bn10,9Q2/26
3.Profit mix (Penman)
VND bn25,0Q2/26
4.Margins & cost structure
%6.6%Q2/26
5.Returns & cash cycle
% · days6.7%Q2/26
6.Earnings quality & cash
VND bn159Q2/26
7.Asset structure
VND bn587Q2/26
8.Funding & debt health
VND bn · times587Q2/26
9.Revenue backlog
VND bn16,6Q2/26
10.Valuation
times · %16,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %411Q2/26
Adjusted EPS growth, latest quarter
30.6%
Average adjusted EPS growth, 3 quarters
-55.5%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26